Zhirui Wang1, Tong Xie1, Cheng Mu2, Chunhua Wang2, Hanfang Ju2, Hui Zhao2, Rui Sun2. 1. Department of Microbiology, Tianjin Centers for Disease Control and Prevention, Tianjin, China. 2. Tuberculosis Reference Laboratory, Tianjin Center for Tuberculosis Control, Tianjin, China.
Abstract
BACKGROUND: Ofloxacin (OFX) resistant Mycobacterium tuberculosis (MTB) isolates have been increasingly observed and are a major concern in recent years. This study investigated the genetic mutations associated with OFX resistance among clinical OFX mono-resistant MTB isolates from new and previously treated tuberculosis patients. METHODS: A total of 50 unrelated OFX mono-resistant MTB isolates were analyzed. For all isolates, the quinolone resistance determining regions of gyrA and gyrB were PCR amplified and sequenced. RESULTS: Single mutations in the quinolone resistance determining regions of gyrA (positions D94A, G, N, and Y; A90V; and S91P) and gyrB (positions T539A and E540D) were observed in 62% (31/50) and 4% (2/50) of all OFX mono-resistant isolates, respectively. No differences were detected between the proportions of isolates with mutations in gyrA/gyrB from new and previously treated tuberculosis patients (P=.820). CONCLUSIONS: Although mutations in gyrB were rare, they were as important as mutations in gyrA in predicting OFX resistance in MTB in Tianjin, China.
BACKGROUND:Ofloxacin (OFX) resistant Mycobacterium tuberculosis (MTB) isolates have been increasingly observed and are a major concern in recent years. This study investigated the genetic mutations associated with OFX resistance among clinical OFX mono-resistant MTB isolates from new and previously treated tuberculosispatients. METHODS: A total of 50 unrelated OFX mono-resistant MTB isolates were analyzed. For all isolates, the quinolone resistance determining regions of gyrA and gyrB were PCR amplified and sequenced. RESULTS: Single mutations in the quinolone resistance determining regions of gyrA (positions D94A, G, N, and Y; A90V; and S91P) and gyrB (positions T539A and E540D) were observed in 62% (31/50) and 4% (2/50) of all OFX mono-resistant isolates, respectively. No differences were detected between the proportions of isolates with mutations in gyrA/gyrB from new and previously treated tuberculosispatients (P=.820). CONCLUSIONS: Although mutations in gyrB were rare, they were as important as mutations in gyrA in predicting OFX resistance in MTB in Tianjin, China.
Authors: I Kontsevaya; S Mironova; V Nikolayevskyy; Y Balabanova; S Mitchell; F Drobniewski Journal: J Clin Microbiol Date: 2011-06-01 Impact factor: 5.948
Authors: Raquel Moure; Griselda Tudó; Rebeca Medina; Eva Vicente; José María Caldito; Maria Gemma Codina; Pere Coll; Montserrat Español; Julian Gonzalez-Martin; Emma Rey-Jurado; Margarita Salvadó; Maria Teresa Tórtola; Fernando Alcaide Journal: Tuberculosis (Edinb) Date: 2013-07-29 Impact factor: 3.131
Authors: Mradula Singh; G P S Jadaun; K Srivastava; Vipin Chauhan; Ritu Mishra; Kavita Gupta; Surya Nair; D S Chauhan; V D Sharma; K Venkatesan; V M Katoch Journal: Indian J Med Res Date: 2011-05 Impact factor: 2.375
Authors: Keira A Cohen; Thomas Abeel; Abigail Manson McGuire; Christopher A Desjardins; Vanisha Munsamy; Terrance P Shea; Bruce J Walker; Nonkqubela Bantubani; Deepak V Almeida; Lucia Alvarado; Sinéad B Chapman; Nomonde R Mvelase; Eamon Y Duffy; Michael G Fitzgerald; Pamla Govender; Sharvari Gujja; Susanna Hamilton; Clinton Howarth; Jeffrey D Larimer; Kashmeel Maharaj; Matthew D Pearson; Margaret E Priest; Qiandong Zeng; Nesri Padayatchi; Jacques Grosset; Sarah K Young; Jennifer Wortman; Koleka P Mlisana; Max R O'Donnell; Bruce W Birren; William R Bishai; Alexander S Pym; Ashlee M Earl Journal: PLoS Med Date: 2015-09-29 Impact factor: 11.069
Authors: Fernanda Maruri; Yan Guo; Amondrea Blackman; Yuri F van der Heijden; Peter F Rebeiro; Timothy R Sterling Journal: Clin Infect Dis Date: 2021-06-01 Impact factor: 9.079
Authors: Thales Alves Campelo; Paulo Rafael Cardoso de Sousa; Lucas de Lima Nogueira; Cristiane Cunha Frota; Paulo Renato Zuquim Antas Journal: Access Microbiol Date: 2021-08-02